{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:13:38Z","timestamp":1793294018046,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T00:00:00Z","timestamp":1668556800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA016672"],"award-info":[{"award-number":["CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA195524"],"award-info":[{"award-number":["R01 CA195524"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.jhepr.2022.100628","type":"journal-article","created":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T20:43:07Z","timestamp":1669063387000},"page":"100628","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Spatial molecular and cellular determinants of STAT3 activation in liver fibrosis progression in non-alcoholic fatty liver disease"],"prefix":"10.1016","volume":"5","author":[{"given":"Jingjing","family":"Jiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica I.","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar A.","family":"Saldarriaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa M.","family":"Solis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8492-8460","authenticated-orcid":false,"given":"David J.","family":"Tweardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipen M.","family":"Maru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0645-7621","authenticated-orcid":false,"given":"Heather L.","family":"Stevenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2054-684X","authenticated-orcid":false,"given":"Laura","family":"Beretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2022.100628_bib1","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/gutjnl-2019-318813","article-title":"Epidemiology of chronic liver diseases in the USA in the past three decades","volume":"69","author":"Younossi","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2022.100628_bib2","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.cgh.2020.05.064","article-title":"Nonalcoholic steatohepatitis is the most rapidly increasing indication for liver transplantation in the United States","volume":"19","author":"Younossi","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2022.100628_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/joim.13380","article-title":"Inflammatory and fibrotic mechanisms in NAFLD-Implications for new treatment strategies","volume":"291","author":"Lee","year":"2022","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.jhepr.2022.100628_bib4","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jhepr.2022.100628_bib5","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1053\/j.gastro.2020.01.043","article-title":"Association between fibrosis stage and outcomes of patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"158","author":"Taylor","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2022.100628_bib6","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis","volume":"65","author":"Dulai","year":"2017","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.jhepr.2022.100628_bib7","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1002\/hep4.1935","article-title":"Predicting NAFLD prevalence in the United States using National Health and Nutrition Examination Survey 2017-2018 transient elastography data and application of machine learning","volume":"6","author":"Noureddin","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhepr.2022.100628_bib8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1124\/mi.11.1.4","article-title":"STAT3 signaling: anticancer strategies and challenges","volume":"11","author":"Johnston","year":"2011","journal-title":"Mol Interv"},{"key":"10.1016\/j.jhepr.2022.100628_bib9","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3390\/cancers6020897","article-title":"STAT3 target genes relevant to human cancers","volume":"6","author":"Carpenter","year":"2014","journal-title":"Cancers"},{"key":"10.1016\/j.jhepr.2022.100628_bib10","doi-asserted-by":"crossref","first-page":"536","DOI":"10.7150\/ijbs.7.536","article-title":"Signal transducer and activator of transcription 3 in liver diseases: a novel therapeutic target","volume":"7","author":"Wang","year":"2011","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.jhepr.2022.100628_bib11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13000-018-0698-8","article-title":"Expression patterns of STAT3, ERK and estrogen-receptor alpha are associated with development and histologic severity of hepatic steatosis: a retrospective study","volume":"13","author":"Choi","year":"2018","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.jhepr.2022.100628_bib12","doi-asserted-by":"crossref","first-page":"7243","DOI":"10.1073\/pnas.1507499112","article-title":"Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition","volume":"112","author":"Su","year":"2015","journal-title":"Proc Natl Acad Sci United States America"},{"key":"10.1016\/j.jhepr.2022.100628_bib13","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.alcohol.2007.04.008","article-title":"Liver regeneration is suppressed in alcoholic cirrhosis: correlation with decreased STAT3 activation","volume":"41","author":"Horiguchi","year":"2007","journal-title":"Alcohol"},{"key":"10.1016\/j.jhepr.2022.100628_bib14","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1136\/jcp.2006.036970","article-title":"Altered p-STAT3 (tyr705) expression is associated with histological grading and intratumour microvessel density in hepatocellular carcinoma","volume":"60","author":"Yang","year":"2007","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.jhepr.2022.100628_bib15","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.2147\/OTT.S156198","article-title":"Clinicopathological significance and prognostic role of p-STAT3 in patients with hepatocellular carcinoma","volume":"11","author":"Liang","year":"2018","journal-title":"OncoTargets Ther"},{"key":"10.1016\/j.jhepr.2022.100628_bib16","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.cell.2018.09.053","article-title":"Obesity drives STAT-1-dependent NASH and STAT-3-dependent HCC","volume":"175","author":"Grohmann","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.jhepr.2022.100628_bib17","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.1158\/1078-0432.CCR-16-2253","article-title":"Multifunctional effects of a small-molecule STAT3 inhibitor on NASH and hepatocellular carcinoma in mice","volume":"23","author":"Jung","year":"2017","journal-title":"Clin Cancer Res : official J Am Assoc Cancer Res"},{"key":"10.1016\/j.jhepr.2022.100628_bib18","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1038\/s41374-018-0127-3","article-title":"The STAT3 inhibitor S3I-201 suppresses fibrogenesis and angiogenesis in liver fibrosis","volume":"98","author":"Wang","year":"2018","journal-title":"Lab Invest"},{"key":"10.1016\/j.jhepr.2022.100628_bib19","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2022.100628_bib20","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/1471-2164-13-296","article-title":"ReadqPCR and NormqPCR: R packages for the reading, quality checking and normalisation of RT-qPCR quantification cycle (Cq) data","volume":"13","author":"Perkins","year":"2012","journal-title":"BMC Genomics"},{"key":"10.1016\/j.jhepr.2022.100628_bib21","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1038\/s41467-018-06318-7","article-title":"Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations","volume":"9","author":"MacParland","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhepr.2022.100628_bib22","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.cell.2018.02.001","article-title":"Mapping the mouse cell atlas by microwell-seq","volume":"172","author":"Han","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.jhepr.2022.100628_bib23","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/hep.30919","article-title":"CREBZF as a key regulator of STAT3 pathway in the control of liver regeneration in mice","volume":"71","author":"Hu","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2022.100628_bib24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/cr.2010.183","article-title":"NF-kappaB and STAT3 - key players in liver inflammation and cancer","volume":"21","author":"He","year":"2011","journal-title":"Cel Res"},{"key":"10.1016\/j.jhepr.2022.100628_bib25","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1053\/j.gastro.2012.05.049","article-title":"Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice","volume":"143","author":"Meng","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2022.100628_bib26","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1136\/gutjnl-2016-313392","article-title":"The HLF\/IL-6\/STAT3 feedforward circuit drives hepatic stellate cell activation to promote liver fibrosis","volume":"67","author":"Xiang","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2022.100628_bib27","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3389\/fonc.2018.00357","article-title":"Transforming growth factor-beta-induced cell plasticity in liver fibrosis and hepatocarcinogenesis","volume":"8","author":"Fabregat","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.jhepr.2022.100628_bib28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1369\/0022155415627681","article-title":"TGF-beta\/SMAD pathway and its regulation in hepatic fibrosis","volume":"64","author":"Xu","year":"2016","journal-title":"J\u00a0Histochem Cytochem : official J Histochem Soc"},{"key":"10.1016\/j.jhepr.2022.100628_bib29","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1073\/pnas.0511167103","article-title":"Galectin-3 regulates myofibroblast activation and hepatic fibrosis","volume":"103","author":"Henderson","year":"2006","journal-title":"Proc Natl Acad Sci United States America"},{"key":"10.1016\/j.jhepr.2022.100628_bib30","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2119\/molmed.2014.00178","article-title":"Galectin-3 ablation enhances liver steatosis, but attenuates inflammation and IL-33-dependent fibrosis in obesogenic mouse model of nonalcoholic steatohepatitis","volume":"21","author":"Jeftic","year":"2015","journal-title":"Mol Med"},{"key":"10.1016\/j.jhepr.2022.100628_bib31","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.bbadis.2014.07.025","article-title":"Stat3 signaling activation crosslinking of TGF-beta1 in hepatic stellate cell exacerbates liver injury and fibrosis","volume":"1842","author":"Xu","year":"2014","journal-title":"Biochim Biophys Acta"},{"issue":"42","key":"10.1016\/j.jhepr.2022.100628_bib32","doi-asserted-by":"crossref","first-page":"30708","DOI":"10.1074\/jbc.M113.478685","article-title":"Transforming growth factor-beta (TGF-beta)-mediated connective tissue growth factor (CTGF) expression in hepatic stellate cells requires Stat3 signaling activation","volume":"288","author":"Liu","year":"2013","journal-title":"J\u00a0Biol Chem"},{"issue":"10","key":"10.1016\/j.jhepr.2022.100628_bib33","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1074\/jbc.M116.773085","article-title":"Transforming growth factor-beta (TGF-beta) directly activates the JAK1-STAT3 Axis to induce hepatic fibrosis in coordination with the SMAD pathway","volume":"292","author":"Tang","year":"2017","journal-title":"J\u00a0Biol Chem"},{"issue":"9","key":"10.1016\/j.jhepr.2022.100628_bib34","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.3390\/cells10092184","article-title":"Perilipin 5 ameliorates hepatic stellate cell activation via SMAD2\/3 and SNAIL signaling pathways and suppresses STAT3 activation","volume":"10","author":"Cierpka","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jhepr.2022.100628_bib35","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/liv.15182","article-title":"Anti-CD47 antibody treatment attenuates liver inflammation and fibrosis in experimental non-alcoholic steatohepatitis models","volume":"42","author":"Gwag","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2022.100628_bib36","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/s41586-019-1631-3","article-title":"Resolving the fibrotic niche of human liver cirrhosis at single-cell level","volume":"575","author":"Ramachandran","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jhepr.2022.100628_bib37","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1039\/C8BM01347K","article-title":"IL-10-secreting human MSCs generated by TALEN gene editing ameliorate liver fibrosis through enhanced anti-fibrotic activity","volume":"7","author":"Choi","year":"2019","journal-title":"Biomater Sci"},{"issue":"4","key":"10.1016\/j.jhepr.2022.100628_bib38","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/hep.32428","article-title":"Dual roles of B lymphocytes in mouse models of diet-induced nonalcoholic fatty liver disease","volume":"76","author":"Karl","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2022.100628_bib39","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1002\/hep.31215","article-title":"Transcriptional dynamics of hepatic sinusoid-associated cells after liver injury","volume":"72","author":"Terkelsen","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2022.100628_bib40","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.3389\/fimmu.2019.02882","article-title":"Interplay between macrophages and angiogenesis: a double-edged sword in liver disease","volume":"10","author":"Ramirez-Pedraza","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhepr.2022.100628_bib41","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1053\/j.gastro.2014.08.039","article-title":"Tumor-associated macrophages produce interleukin 6 and signal via STAT3 to promote expansion of human hepatocellular carcinoma stem cells","volume":"147","author":"Wan","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2022.100628_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12598","article-title":"LncSox4 promotes the self-renewal of liver tumour-initiating cells through Stat3-mediated Sox4 expression","volume":"7","author":"Chen","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhepr.2022.100628_bib43","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jhep.2016.01.019","article-title":"Long non-coding RNA DILC regulates liver cancer stem cells via IL-6\/STAT3 axis","volume":"64","author":"Wang","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2022.100628_bib44","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/hep.27968","article-title":"Signal transducer and activator of transcription 3-mediated CD133 up-regulation contributes to promotion of hepatocellular carcinoma","volume":"62","author":"Won","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2022.100628_bib45","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1053\/j.gastro.2015.11.002","article-title":"TLR4 signaling via NANOG cooperates with STAT3 to activate Twist1 and promote formation of tumor-initiating stem-like cells in livers of mice","volume":"150","author":"Uthaya Kumar","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2022.100628_bib46","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.biocel.2009.11.006","article-title":"The role of stem cells in liver repair and fibrosis","volume":"43","author":"Greenbaum","year":"2011","journal-title":"Int J Biochem Cel Biol"},{"key":"10.1016\/j.jhepr.2022.100628_bib47","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jhep.2013.08.012","article-title":"The intrahepatic signalling niche of hedgehog is defined by primary cilia positive cells during chronic liver injury","volume":"60","author":"Grzelak","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2022.100628_bib48","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1158\/0008-5472.CAN-14-1254","article-title":"miR-21 inhibition reduces liver fibrosis and prevents tumor development by inducing apoptosis of CD24+ progenitor cells","volume":"75","author":"Zhang","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhepr.2022.100628_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.732929","article-title":"Liver zonation - revisiting old questions with new technologies","volume":"12","author":"Cunningham","year":"2021","journal-title":"Front Physiol"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555922002002?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555922002002?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T04:07:15Z","timestamp":1778904435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555922002002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S2589555922002002"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2022.100628","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spatial molecular and cellular determinants of STAT3 activation in liver fibrosis progression in non-alcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2022.100628","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"100628"}}